In clinical trials, Blujepa showed efficacy similar or superior to a leading existing UTI ... have a new medication option now that the U.S. Food and Drug Administration (FDA) has approved the ...

March 26, 2025 — The FDA has approved a new medication to treat uncomplicated ... About half of all women get a UTI at least once in their lifetime, and 30% may face recurring infections.

a new report claims that a popular over-the-counter drug used to treat UTI symptoms has been linked to cancer concerns. But this medication has not been formally approved by the Food and Drug ...

Blujepa is approved to treat females 12 and older with uncomplicated urinary tract infections, or UTIs. About half of all women will experience a UTI at some point in their lives, and about 30% ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary ... adults and pediatric patients 12 and older. A UTI is considered uncomplicated if it occurs in a female ...

Blujepa is approved to treat females 12 and older with uncomplicated urinary tract infections, or UTIs. About half of all women will experience a UTI at some point in their lives, and about 30% ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving ... Meanwhile, the FDA also approved Genetech's TNKase to treat adults who suffer acute ischemic ...

The Food and Drug Administration (FDA) has approved a new drug ... and half of all women experience a UTI in their lifetime, with some 30% of women suffering from recurrent episodes.

Currently, PPDirect offers services like birth control, UTI treatment ... they expect from PPIL.” Medication abortion, which involves mifepristone, has been FDA-approved for over 20 years ...

In clinical trials, Blujepa showed efficacy similar or superior to a leading existing UTI ... have a new medication option now that the U.S. Food and Drug Administration (FDA) has approved the ...